Meridian Bioscience
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch VIVO and buy or sell other stocks, ETFs, and their options commission-free!About VIVO
Meridian Bioscience, Inc. engages in the development, production, sale, and distribution of diagnostic products. Its platforms include molecular, immunoassay, urea breath, and blood chemistry.
CEOAndrew S. Kitzmiller, CPA
CEOAndrew S. Kitzmiller, CPA
Employees—
Employees—
HeadquartersCincinnati, Ohio
HeadquartersCincinnati, Ohio
Founded1976
Founded1976
Employees—
Employees—
VIVO Key Statistics
Market cap1.49B
Market cap1.49B
Price-Earnings ratio35.49
Price-Earnings ratio35.49
Dividend yield—
Dividend yield—
Average volume1.40M
Average volume1.40M
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$34.38
52 Week high$34.38
52 Week low$21.09
52 Week low$21.09
Stock Snapshot
The current Meridian Bioscience(VIVO) stock price is $33.97, with a market capitalization of 1.49B. The stock trades at a price-to-earnings (P/E) ratio of 35.49.
On 2025-11-15, Meridian Bioscience(VIVO) shares started trading at —, with intraday highs of — and lows of —.
Trading volume for Meridian Bioscience(VIVO) stock has reached 0, versus its average volume of 1.4M.
The stock's 52-week range extends from a low of $21.09 to a high of $34.38.
The stock's 52-week range extends from a low of $21.09 to a high of $34.38.
People also own
Based on the portfolios of people who own VIVO. This list is generated using Robinhood data, and it’s not a recommendation.